Otwarty dostęp

Detecting EGFR mutations in patients with non-small cell lung cancer

, , , , , , , ,  oraz   
29 paź 2018

Zacytuj
Pobierz okładkę

Figure 1

Plot shows EGFR positive samples for the exon 19 deletion; amplification of the internal control (Ctrl assay) with CT 26.45 and amplification for mutational assay (del assay) with CT 29.42. ΔCT = 2.97 (calculated by the formula ΔCT = mutation CT-control CT). The ΔCT cutoff value for this mutational assay was 9.06.
Plot shows EGFR positive samples for the exon 19 deletion; amplification of the internal control (Ctrl assay) with CT 26.45 and amplification for mutational assay (del assay) with CT 29.42. ΔCT = 2.97 (calculated by the formula ΔCT = mutation CT-control CT). The ΔCT cutoff value for this mutational assay was 9.06.

Types of the mutations detected_

Mutations DetectedPatients (n)%
Deletions in exon 193156.4
L858R2036.4
Insertions in exon 2023.6
Deletions in exon 19 and T790M11.8
Deletions in exon 19 and S768I11.8

Clinicopathological features of the 551 patients_

Clinicopathological FeaturesTotal Patients (n)Patients with Mutations or Wild-Type (n)p Value
MutationsWild-Type
Gender:
males40716391<0.0001
females14439105
Histology:
adenocarcinomas27641235
other types275142610.000232
Smoking history:
smokers33823315
non smokers213321810.002807
Język:
Angielski
Częstotliwość wydawania:
2 razy w roku
Dziedziny czasopisma:
Medycyna, Podstawowe nauki medyczne, Podstawowe nauki medyczne, inne